Viatris Inc (VTRS)
13.37
+0.12
(+0.91%)
USD |
NASDAQ |
Nov 22, 16:00
13.38
0.00 (0.00%)
After-Hours: 20:00
Viatris Enterprise Value: 29.66B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 29.66B |
| November 21, 2024 | 29.52B |
| November 20, 2024 | 29.37B |
| November 19, 2024 | 29.28B |
| November 18, 2024 | 29.22B |
| November 15, 2024 | 29.02B |
| November 14, 2024 | 28.77B |
| November 13, 2024 | 29.22B |
| November 12, 2024 | 29.14B |
| November 11, 2024 | 29.33B |
| November 08, 2024 | 29.17B |
| November 07, 2024 | 29.43B |
| November 06, 2024 | 27.56B |
| November 05, 2024 | 27.56B |
| November 04, 2024 | 27.37B |
| November 01, 2024 | 27.57B |
| October 31, 2024 | 27.55B |
| October 30, 2024 | 27.89B |
| October 29, 2024 | 27.71B |
| October 28, 2024 | 27.74B |
| October 25, 2024 | 27.36B |
| October 24, 2024 | 27.40B |
| October 23, 2024 | 27.49B |
| October 22, 2024 | 27.63B |
| October 21, 2024 | 27.51B |
| Date | Value |
|---|---|
| October 18, 2024 | 27.74B |
| October 17, 2024 | 27.68B |
| October 16, 2024 | 27.81B |
| October 15, 2024 | 27.83B |
| October 14, 2024 | 27.30B |
| October 11, 2024 | 27.29B |
| October 10, 2024 | 27.23B |
| October 09, 2024 | 27.32B |
| October 08, 2024 | 27.21B |
| October 07, 2024 | 27.23B |
| October 04, 2024 | 27.54B |
| October 03, 2024 | 27.34B |
| October 02, 2024 | 27.39B |
| October 01, 2024 | 27.42B |
| September 30, 2024 | 27.56B |
| September 27, 2024 | 29.74B |
| September 26, 2024 | 29.83B |
| September 25, 2024 | 29.41B |
| September 24, 2024 | 29.62B |
| September 23, 2024 | 29.65B |
| September 20, 2024 | 29.55B |
| September 19, 2024 | 30.16B |
| September 18, 2024 | 30.16B |
| September 17, 2024 | 30.06B |
| September 16, 2024 | 30.05B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.93B
Minimum
Mar 12 2020
47.41B
Maximum
Dec 31 2020
31.23B
Average
30.83B
Median
Apr 05 2024
Enterprise Value Benchmarks
| Lexicon Pharmaceuticals Inc | 153.64M |
| Moderna Inc | 8.953B |
| Baxter International Inc | 28.54B |
| Gilead Sciences Inc | 130.53B |
| Perspective Therapeutics Inc | -31.63M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 94.80M |
| Revenue (Quarterly) | 3.751B |
| Total Expenses (Quarterly) | 3.494B |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 38.90% |
| Profit Margin (Quarterly) | 2.53% |
| Earnings Yield | -5.53% |
| Operating Earnings Yield | 1.34% |
| Normalized Earnings Yield | -2.989 |